ClassID:

190981

G06F19/706 - CPC Classification

Classification description:

Recent Application in this class:
#1
20190243946
2019-08-08

Optimizing Successful Outcomes for Repurposing Existing Pharmaceutical Compounds

#2
20190243945
2019-08-08

Leveraging genomic, phenotypic and pharmacological data to cure disease

#3
20190108322
2019-04-11

System and method for computing drug controlled release performance using images

#4
20190065698
2019-02-28

Mechanistic Predictive Model Of Pharmacokinetic Profile Of Oral Compounds In Fasted And Fed State

#5
20190065697
2019-02-28

Methods and systems for calculating free energy differences using an alchemical restraint potential

#6
20190042705
2019-02-07

REALIZATION METHOD FOR COMPUTER-AIDED SCREENING OF SMALL MOLECULE COMPOUND TARGET APTAMER

#7
20190042690
2019-02-07

METHOD AND DEVICE FOR CALCULATING BINDING FREE ENERGY, AND PROGRAM

#8
20190026440
2019-01-24

NUCLEAR RECEPTOR SET DOMAIN CONTAINING PROTEIN 2 TRANSITION STATE AND USES THEREOF

#9
20190026423
2019-01-24

Cycle Closure Estimation of Relative Binding Affinities and Errors

#10
20190004058
2019-01-03

Methods of screening

#11
20180373846
2018-12-27

METHODS AND SYSTEMS FOR ORGANIC SOLUTE SAMPLING OF AQUEOUS AND HETEROGENEOUS ENVIRONMENTS

#12
20180363021
2018-12-20

Method for designing compounds and compositions useful for targeting high stoichiometric complexes to treat conditions, including treatment of viruses, bacteria, and cancers having acquired drug resistance

#13
20180341754
2018-11-29

Computational method for classifying and predicting ligand docking conformations

#14
20180300461
2018-10-18

LIBRARIES OF COMPOUNDS HAVING DESIRED PROPERTIES AND METHODS FOR MAKING AND USING THEM

#15
20180300447
2018-10-18

METHOD FOR BINDING SITE IDENTIFICATION BY MOLECULAR DYNAMICS SIMULATION (SILCS: SITE IDENTIFICATION BY LIGAND COMPETITIVE SATURATION)

#16
20180285534
2018-10-04

Methods and apparatus for double-integration orthogonal space tempering

#17
20180261331
2018-09-13

Computer-assisted modeling for treatment design

#18
20180239878
2018-08-23

DNA methyltransferase 1 transition state structure and uses thereof

#19
20180239877
2018-08-23

METHOD, COMPUTER PROGRAM, VIDEO GAME AND SYSTEM FOR OPTIMIZING A MOLECULE FOR MEDICAL APPLICATIONS

#20
20180238869
2018-08-23

USES OF SYSTEMS WITH DEGREES OF FREEDOM POISED BETWEEN FULLY QUANTUM AND FULLY CLASSICAL STATES

#21
20180225427
2018-08-09

BRD2 PROTEIN INHIBITOR COMPOUNDS AND USES THEREOF

#22
20180218129
2018-08-02

Method and system for drug virtual screening and construction of focused screening library

#23
20180189460
2018-07-05

LPA2 RECEPTOR-SPECIFIC BENZOIC ACID DERIVATIVES

#24
20180101660
2018-04-12

Reconstruction and simulation of neocortical microcircuitry

#25
20180021259
2018-01-25

DYE-STABILIZED NANOPARTICLES AND METHODS OF THEIR MANUFACTURE AND THERAPEUTIC USE

#26
20180009853
2018-01-11

Crystal structure of the large ribosomal subunit from

#27
20170344699
2017-11-30

WATER-SOLUBLE MEMBRANE PROTEINS AND METHODS FOR THE PREPARATION AND USE THEREOF

#28
20170336402
2017-11-23

BINDING ASSAY

#29
20170273611
2017-09-28

SYSTEMS AND METHODS FOR DISCOVERY AND CHARACTERIZATION OF NEUROACTIVE DRUGS

#30
20170227545
2017-08-10

REACTIVITY-BASED SCREENING FOR NATURAL PRODUCT DISCOVERY

#31
20170052157
2017-02-23

Method of and apparatus for formulating multicomponent drug

#32
20170046504
2017-02-16

SYSTEM FOR DETERMINING A SUITABILITY OF AN ACTIVE INGREDIENT TO BE APPLIED TRANSDERMALLY OR TRANSMUCOSALLY AND CORRESPONDING METHOD

#33
20160378946
2016-12-29

USING INPUT PROPERTIES AND SYSTEM PROPERTIES TO PREDICT A TIME-DEPENDENT RESPONSE OF A COMPONENT OF A SYSTEM TO AN INPUT INTO THE SYSTEM

#34
20160378912
2016-12-29

STRUCTURE-BASED MODELING AND TARGET-SELECTIVITY PREDICTION

#35
20160357945
2016-12-08

METHODS AND SYSTEMS FOR ORGANIC SOLUTE SAMPLING OF AQUEOUS AND HETEROGENEOUS ENVIRONMENTS

#36
20160340324
2016-11-24

METHODS AND COMPOSITIONS FOR TREATING CANCER

#37
20160314241
2016-10-27

DRUG DISCOVERY METHOD

#38
20160313325
2016-10-27

Drug target site within GP120 of HIV

#39
20160292394
2016-10-06

METHOD AND DEVICE FOR PARTITIONING A MOLECULE

#40
20160196412
2016-07-07

Molecules

#41
20160140327
2016-05-19

Generating drug repositioning hypotheses based on integrating multiple aspects of drug similarity and disease similarity

#42
20160070850
2016-03-10

Method for binding site identification by molecular dynamics simulation (silcs: site identification by ligand competitive saturation)

#43
20160019374
2016-01-21

METHODS FOR ESTABLISHING COMBINATIONS OF KINASE INHIBITORS FOR THE TREATMENT OF MEDICAL CONDITIONS

#44
20160004812
2016-01-07

Pharmacogenic therapies targeting the metal-ion transcriptional regulation machinery in bacteria

#45
20150371009
2015-12-24

DRUG IDENTIFICATION MODELS AND METHODS OF USING THE SAME TO IDENTIFY COMPOUNDS TO TREAT DISEASE

#46
20150313898
2015-11-05

Compounds that inhibit human DNA ligases and methods of treating cancer

#47
20150310006
2015-10-29

Collaborative drug discovery system

#48
20150299804
2015-10-22

BIOMARKERS FOR PREDICTING CLINICAL RESPONSE OF CANCER PATIENTS TO TREATMENT WITH IMMUNOTHERAPEUTIC AGENT

#49
20150292023
2015-10-15

Materials and Methods Related to NSAID Chemoprevention in Colorectal Cancer

#50
20150278485
2015-10-01

DESIGNING COMBINATIONS THERAPIES OF NON-INTERACTING DRUGS FOR EVOLUTIONARY DYNAMICS OF DISEASE USING OPTIMAL CONTROL

#51
20150278432
2015-10-01

Method and system for molecular dynamics simulation with stability control

#52
20150269356
2015-09-24

Libraries of compounds having desired properties and methods for making and using them

#53
20150261926
2015-09-17

Data analysis and predictive systems and related methodologies

#54
20150254433
2015-09-10

Methods and Models for Determining Likelihood of Cancer Drug Treatment Success Utilizing Predictor Biomarkers, and Methods of Diagnosing and Treating Cancer Using the Biomarkers

#55
20150247133
2015-09-03

Methods and tools for identification of RSK/MSK kinase inhibitors

#56
20150231126
2015-08-20

COMBINATIONS OF 5-HT2A INVERSE AGONISTS AND ANTAGONISTS WITH ANTIPSYCHOTICS

#57
20150161359
2015-06-11

METHODS FOR SAFETY TESTING

#58
20150154345
2015-06-04

Reprogramming effector protein interactions to correct epigenetic defects in cancer

#59
20150100286
2015-04-09

Using input properties and system properties to predict a time-dependent response of a component of a system to an input into the system

#60
20150095007
2015-04-02

SITE-SPECIFIC FRAGMENT IDENTIFICATION GUIDED BY SINGLE-STEP FREE ENERGY PERTURBATION CALCULATIONS

#61
20150036889
2015-02-05

Method and system for predicting spatial and temporal distributions of therapeutic substance carriers

#62
20150025871
2015-01-22

Method for aligning molecules in three dimensions based upon their correspondence to an exemplary template molecule for use in performing 3D QSAR analyses

#63
20140358450
2014-12-04

Method of Binding Site and Binding Energy Determination by Mixed Explicit Solvent Simulations

#64
20140356324
2014-12-04

Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof

#65
20140278284
2014-09-18

Methods for shape comparison between drug molecules

#66
20140094457
2014-04-03

Pharmaceutical compositions and treatment of genetic diseases associated with nonsense mediated RNA decay

#67
20140074448
2014-03-13

Crystal structure

#68
20140038168
2014-02-06

Drug target site within gp120 of HIV

#69
20130281318
2013-10-24

Selection of medicaments that modulate the function and activity of interleukin 13

#70
20130268472
2013-10-10

AI for relating herbal ingredients to illnesses classified in traditional chinese medicine/TCM using probabilities and a relevance index

#71
20130217090
2013-08-22

Crystal structure of glutaminyl cyclase

#72
20130144541
2013-06-06

Mass spectrometry-cleavable cross-linking agents to facilitate structural analysis of proteins and protein complexes, and method of using same

#73
20130076752
2013-03-28

Computing method and computing apparatus

#74
20130046076
2013-02-21

Crystal structure of amino terminal portion of influenza virus polymerase PA subunit and use thereof

#75
20120308520
2012-12-06

Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof

#76
20120303292
2012-11-29

Binding affinity scoring with penalty for breaking conjugation between aromatic ligand groups

#77
20120239356
2012-09-20

Free energy difference estimation method and simulation apparatus

#78
20120087911
2012-04-12

CRYSTAL STRUCTURE

#79
20120071333
2012-03-22

Uses of systems with degrees of freedom poised between fully quantum and fully classical states

#80
20120015834
2012-01-19

Methods for artificial combinatorial control of biological systems

#81
20110288083
2011-11-24

Method of treating cancer by inhibition of protein kinase-like endoplasmic reticulum protein kinase

#82
20110237458
2011-09-29

Drug discovery method

#83
20110169937
2011-07-14

Mode of action screening method

#84
20100233189
2010-09-16

Crystal structure of thyroid stimulating hormone receptor

#85
20100099891
2010-04-22

Estimation of protein-compound interaction and rational design of compound library based on chemical genomic information

#86
20060177869
2006-08-10

Method and system for analysis of compounds

#87
20050228592
2005-10-13

Method and device for partitioning a molecule

#88
15910822
2018-12-04

Systems and methods for evaluating whether perturbations discriminate an on target effect

#89
15592864
2018-08-28

Methods of treating acanthamoeba infection using apocynin